Security key
46333X108
IRONWOOD PHARMACEUTICALS INC - Class A Stock (IRWD)
CUSIP: 46333X108
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Class A Stock
- Total 13F shares
- 148,541,007
- Total 13F value
- $194,617,095
- Share change
- +2,386,920
- Put/Call ratio
- 0.1%
- SEC-reported price per share
- $1.31
- Number of holders
- 160
- Value change
- +$6,212,194
- Number of buys
- 77
- Number of sells
- 65
- Shares outstanding
- 165,105,778
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
160
Top holders
10
IRWD full security history
Ownership snapshot
Full 13F holder table
IRONWOOD PHARMACEUTICALS INC SEC filings
IRONWOOD PHARMACEUTICALS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13F
13D/G
3/4/5
Lead comparable stake: 10%
13D/G row: VANGUARD GROUP INC
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
10%
RENAISSANCE TECHNOLOGIES LLC
5.4%
STATE STREET CORP
2.2%
BARCLAYS PLC
2%
Pacer Advisors, Inc.
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
10%
from 13D/G
|
$11,616,926
16,202,129 shares
|
— | 30 Jun 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13D/G
13F
Company
|
5.4%
|
$7,565,534
8,597,198 shares
|
$0 | 15 May 2024 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
2.2%
|
$3,078,494
3,498,289 shares
|
-$4,250,865 | 31 Mar 2025 |
| BARCLAYS PLC |
13D/G
13F
Company
|
2%
|
$4,149,704
3,167,713 shares
|
-$10,435,649 | 30 Sep 2025 |
| Pacer Advisors, Inc. |
13D/G
Pacer US Small Cap Cash Cows ETF
|
1.1%
|
$1,574,406
1,789,098 shares
|
-$8,748,672 | 31 Mar 2025 |
| Andrew Dreyfus |
3/4/5
Director
|
0.14%
|
$212,331
228,313 shares
|
— | 10 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
160
Shares
148,541,007
Rows available
160
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
151
Q3 2025 holders
160
Holder diff
9
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|